Lategan, Thomas W.
Wang, Laurene
Sprague, Tiffany N.
Rousseau, Franck S.
Article History
Accepted: 19 February 2021
First Online: 30 March 2021
Declarations
:
: This study was supported in its entirety by Banner Life Sciences. Banner Life Sciences paid the open access fee.
: Thomas W. Lategan, Tiffany N. Sprague, and Franck S. Rousseau are employees of Banner Life Sciences. Laurene Wang is a paid consultant to Banner Life Sciences.
: All pertinent study documents were reviewed, and the study protocol approved by the Chesapeake Institutional Review Board prior to study initiation.
: All subjects provided written informed consent prior to the conduct of study-related procedures.
: Not applicable.
: This phase I study was retrospectively registered with ClinicalTrials.gov (NCT04570670) on 30 September, 2020.
: Not applicable.
: TWL: conceptualization, writing, original draft preparation; LW: study design, conduct and oversight, clinical research organization selection, sample size estimation, study result review, and data analysis, interpretation, and presentation; FR: conceptualization, supervision; TNS: project administration. All authors have read, commented on the manuscript, and approved the final manuscript. The authors were responsible for all content and editorial decisions.